Lfa Lugano Financial Advisors Sa Vertex Pharmaceuticals Inc Transaction History
Lfa Lugano Financial Advisors Sa
- $168 Million
- Q2 2025
A detailed history of Lfa Lugano Financial Advisors Sa transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Lfa Lugano Financial Advisors Sa holds 23 shares of VRTX stock, worth $9,275. This represents 0.01% of its overall portfolio holdings.
Number of Shares
23Holding current value
$9,275% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding VRTX
# of Institutions
1,809Shares Held
239MCall Options Held
1.95MPut Options Held
1.14M-
Capital World Investors Los Angeles, CA28.7MShares$11.6 Billion1.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA24MShares$9.67 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.6 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.1MShares$6.5 Billion1.5% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.75 Billion0.2% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $104B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...